Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Draper Q&A: upgrading CAR-T therapy manufacturing

Draper is seeking to update the manufacturing processes and technology used for CAR-T cancer therapies to improve the efficiency and access. The company’s head of precision medicine and cell bioprocessing Jenna Balestrini explains the issues with the current viral vector approach and how Draper’s four modules, and particularly the microfluidics electroporation system, can transform the CAR-T cell therapy space.


Go Top